Aziyo Biologics, Inc. (AZYO) Misses Q2 EPS by 13c

Aziyo Biologics, Inc. (NASDAQ: AZYO) reported Q2 EPS of ($0.69), $0.13 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $11.59 million.

For earnings history and earnings-related data on Aziyo Biologics, Inc. (AZYO) click here.

You May Also Be Interested In

• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• St. Joe Company (JOE) Reports Q1 EPS of $0.24
• VIST Financial Corp. (VIST) Misses Q1 EPS by 19c